Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
NeuroDerm

CTech 24/7

17:12 Navan to file confidentially for IPO, betting on market reopening
16:13 Israel delivers economic decapitation strike on Iranian regime

NeuroDerm

3 stories about NeuroDerm

After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%
27.12.17|Amarelle WenkertU.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report
Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm
19.10.17|Lilach BaumerNeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion
25.07.17|Gil KalianOsaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

NeuroDerm

After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion